| P50 | author | Michele Saviano | Q42602207 |
| | Gianna Palmieri | Q55756045 |
| | Ramanath N Hegde | Q56988501 |
| | Emma Langella | Q56988514 |
| | Paolo Bergamo | Q56988528 |
| | Alberto Luini | Q56988538 |
| | Mosè Rossi | Q69556253 |
| | Menotti Ruvo | Q88043792 |
| | Marta Gogliettino | Q114375367 |
| P2093 | author name string | Annamaria Sandomenico | |
| P2860 | cites work | Proteasome inhibitors in cancer therapy: lessons from the first decade | Q37112347 |
| | Targeting proteins for destruction by the ubiquitin system: implications for human pathobiology | Q37286190 |
| | Dietary polyunsaturated fatty acids as inducers of apoptosis: implications for cancer. | Q37364559 |
| | Conjugated linoleic acid and inflammatory cell signalling | Q37703932 |
| | Solid phase peptide synthesis utilizing 9-fluorenylmethoxycarbonyl amino acids | Q37932475 |
| | Preliminary report: inhibition of cellular proteasome activity by free fatty acids | Q39855345 |
| | Sensitivity of tumor cells to proteasome inhibitors is associated with expression levels and composition of proteasome subunits | Q40027466 |
| | Overexpression of oxidized protein hydrolase protects COS-7 cells from oxidative stress-induced inhibition of cell growth and survival | Q40650740 |
| | Deficiency of acylpeptide hydrolase in small-cell lung carcinoma cell lines | Q41602118 |
| | Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis | Q41714520 |
| | Crystal structure of an acylpeptide hydrolase/esterase from Aeropyrum pernix K1. | Q43016205 |
| | Randomized Double-Blind Placebo-Controlled Trial of Bestatin in Patients With Resected Stage I Squamous-Cell Lung Carcinoma | Q44405219 |
| | Coordination of oxidized protein hydrolase and the proteasome in the clearance of cytotoxic denatured proteins | Q45090238 |
| | Aminopeptidase inhibition as a targeted treatment strategy in myeloma. | Q46048019 |
| | First Archaeal PEPB-Serine Protease Inhibitor from Sulfolobus solfataricus with Noncanonical Amino Acid Sequence in the Reactive-Site Loop | Q46177921 |
| | Multiple proteolytic systems, including the proteasome, contribute to CFTR processing | Q50337154 |
| | Ubiquitin-protein ligase activity of X-linked inhibitor of apoptosis protein promotes proteasomal degradation of caspase-3 and enhances its anti-apoptotic effect in Fas-induced cell death | Q24630370 |
| | MOLMOL: a program for display and analysis of macromolecular structures | Q27860873 |
| | Pathway for degradation of peptides generated by proteasomes: a key role for thimet oligopeptidase and other metallopeptidases | Q28278713 |
| | Identification and functional characterization of N-terminally acetylated proteins in Drosophila melanogaster | Q28471597 |
| | Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors | Q29547463 |
| | Acetylation: a regulatory modification to rival phosphorylation? | Q29614886 |
| | Degradation of CFTR by the ubiquitin-proteasome pathway | Q29616142 |
| | The ubiquitin-proteasome pathway is required for processing the NF-kappa B1 precursor protein and the activation of NF-kappa B | Q29618194 |
| | Cotranslational amino-terminal processing of cytosolic proteins. Cell-free expression of site-directed mutants of human hemoglobin | Q30404689 |
| | Modulation of angiogenesis by a tetrameric tripeptide that antagonizes vascular endothelial growth factor receptor 1. | Q33376945 |
| | Signaling to NF-kappaB: regulation by ubiquitination | Q33693806 |
| | N-terminal acetylation of cellular proteins creates specific degradation signals | Q34095411 |
| | A quick and simple method for the quantitation of lactate dehydrogenase release in measurements of cellular cytotoxicity and tumor necrosis factor (TNF) activity | Q34169361 |
| | Proteasome-mediated degradation of p21 via N-terminal ubiquitinylation. | Q34268195 |
| | The tumor suppressor protein p16(INK4a) and the human papillomavirus oncoprotein-58 E7 are naturally occurring lysine-less proteins that are degraded by the ubiquitin system. Direct evidence for ubiquitination at the N-terminal residue | Q34333425 |
| | NF-kappa B as a therapeutic target in multiple myeloma | Q34521393 |
| | Proteomics analyses reveal the evolutionary conservation and divergence of N-terminal acetyltransferases from yeast and humans | Q34979512 |
| | Fatty acid interactions with proteins: what X-ray crystal and NMR solution structures tell us. | Q35683493 |
| | Conjugated linoleic acids: are they beneficial or detrimental to health? | Q35937622 |
| | Activation of the cell death program by inhibition of proteasome function | Q35964722 |
| | Proteasome inhibition as a novel therapeutic target in human cancer. | Q36014046 |
| | Catabolism of intracellular N-terminal acetylated proteins: involvement of acylpeptide hydrolase and acylase | Q36145998 |
| | Influence of proteasome inhibitors on apoptosis | Q36380960 |
| | Proteasome inhibitors: antitumor effects and beyond | Q36649676 |
| | The proteasome as a potential target for novel anticancer drugs and chemosensitizers | Q36695969 |
| | The ubiquitin-proteasome system and proteasome inhibitors in central nervous system diseases | Q37066006 |
| | Proteasome inhibitors induced caspase-dependent apoptosis and accumulation of p21WAF1/Cip1 in human immature leukemic cells. | Q52968368 |
| | Refinement of the structure of Escherichia coli-derived rat intestinal fatty acid binding protein with bound oleate to 1.75-A resolution. Correlation with the structures of the apoprotein and the protein with bound palmitate | Q54668658 |
| | A novel class of protease targets of phosphatidylethanolamine-binding proteins (PEBP): a study of the acylpeptide hydrolase and the PEBP inhibitor from the archaeon Sulfolobus solfataricus | Q57599845 |
| | Proteolysis: from the lysosome to ubiquitin and the proteasome | Q81354981 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | e25888 | |
| P577 | publication date | 2011-10-10 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Acylpeptide hydrolase inhibition as targeted strategy to induce proteasomal down-regulation | |
| P478 | volume | 6 | |